Your session is about to expire
← Back to Search
Procedure
Hyperfine MRI for Detecting Brain Injury in Pediatric ECMO Patients
N/A
Recruiting
Led By Jessica Wallisch, MD
Research Sponsored by Children's Mercy Hospital Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subjects admitted to the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or the Neonatal Intensive Care Unit
Ages 0-17 years
Must not have
Former or current welders, metal workers, or individuals with a metal injury
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of ecmo treatment period, an average of <2 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to study how often and what type of brain injuries occur in children who need ECMO support. They will use a special MRI machine to track the brain injuries over time and compare them to
Who is the study for?
This trial is for pediatric patients aged 0-17 years who are receiving ECMO support due to conditions like brain injury from lack of oxygen, stroke, or trauma. They must be in the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or Neonatal Intensive Care Unit.
What is being tested?
The study aims to use a portable MRI device called Hyperfine to detect acute brain injuries (ABI) in children on ECMO support. It will track how often and when these injuries occur during treatment compared with routine care imaging.
What are the potential side effects?
Since this trial involves diagnostic imaging rather than medication or invasive procedures, direct side effects from the intervention (Hyperfine MRI) are minimal to none.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child is in the ICU, CICU, or NICU.
Select...
I am 17 years old or younger.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have worked as a welder, metal worker, or have had a metal injury.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of ecmo treatment period, an average of <2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of ecmo treatment period, an average of <2 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support.
Secondary study objectives
Describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Portable MRI ArmExperimental Treatment1 Intervention
All subjects enrolled will be assigned to Arm 1
Find a Location
Who is running the clinical trial?
Children's Mercy Hospital Kansas CityLead Sponsor
257 Previous Clinical Trials
940,466 Total Patients Enrolled
Jessica Wallisch, MDPrincipal InvestigatorChildren's Mercy Kansas City
1 Previous Clinical Trials
20 Total Patients Enrolled